| Drug Name: | Amphetamine (300-62-9) |
|---|---|
| PubChem ID: | 3007 |
| SMILES: | CC(CC1=CC=CC=C1)N |
| InchiKey: | KWTSXDURSIMDCE-UHFFFAOYSA-N |
| Therapeutic Category: | Adrenergic Agents, Adrenergic Uptake Inhibitors, Autonomic Agents, Central Nervous System Agents, Central Nervous System Stimulants, Dopamine Agents, Dopamine Uptake Inhibitors, Membrane Transport Modulators, Neurotransmitter Agents, Neurotransmitter Uptake Inhibitors, Peripheral Nervous System Agents, Sympathomimetics |
| Molecular Weight (dalton) | : | 135.21 |
| LogP | : | 1.5763 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 1 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 26.02 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Chlorpromazine (50-53-3) | Antagonises The Apetite Supressant Effect Of Amfetamines | Antagonistic | Not Understood | Asystole and bradycardia during dipyridamole stress testing in patients receiving beta blockers |
| Cocaine (50-36-2) | Ischaemic Stroke | Additive | Not Clear | Amphetamine poisoning: effectiveness of chlorpromazine |
| Furazolidone (67-45-8) | Rise In Blood Pressure | Antagonistic | Amphetamine interacts with furazolidone gradually after 5 to 10 days of use | The anti-monoamine oxidase effects of furazolidone |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category